These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8476896)
21. Reproducibility of the Banff classification in subclinical kidney transplant rejection. Veronese FV; Manfro RC; Roman FR; Edelweiss MI; Rush DN; Dancea S; Goldberg J; Gonçalves LF Clin Transplant; 2005 Aug; 19(4):518-21. PubMed ID: 16008598 [TBL] [Abstract][Full Text] [Related]
22. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths]. Agozzino L; Thomopoulos K; Esposito S; Agozzino M; De Vivo F; Maiello C; Cotrufo M Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868 [TBL] [Abstract][Full Text] [Related]
23. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy. Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463 [TBL] [Abstract][Full Text] [Related]
24. Banff schema for grading liver allograft rejection: utility in clinical practice. Ormonde DG; de Boer WB; Kierath A; Bell R; Shilkin KB; House AK; Jeffrey GP; Reed WD Liver Transpl Surg; 1999 Jul; 5(4):261-8. PubMed ID: 10388498 [TBL] [Abstract][Full Text] [Related]
25. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. Stewart S; Fishbein MC; Snell GI; Berry GJ; Boehler A; Burke MM; Glanville A; Gould FK; Magro C; Marboe CC; McNeil KD; Reed EF; Reinsmoen NL; Scott JP; Studer SM; Tazelaar HD; Wallwork JL; Westall G; Zamora MR; Zeevi A; Yousem SA J Heart Lung Transplant; 2007 Dec; 26(12):1229-42. PubMed ID: 18096473 [TBL] [Abstract][Full Text] [Related]
26. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. Marboe CC; Billingham M; Eisen H; Deng MC; Baron H; Mehra M; Hunt S; Wohlgemuth J; Mahmood I; Prentice J; Berry G J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S219-26. PubMed ID: 15993777 [TBL] [Abstract][Full Text] [Related]
27. Usefulness of serial monitoring of B-type natriuretic peptide for the detection of acute rejection after heart transplantation. Garrido IP; Pascual-Figal DA; Nicolás F; González-Carrillo MJ; Manzano-Fernández S; Sánchez-Mas J; Valdés-Chavarri M Am J Cardiol; 2009 Apr; 103(8):1149-53. PubMed ID: 19361605 [TBL] [Abstract][Full Text] [Related]
28. Survey of current practice related to grading of rejection in cardiac transplant recipients in North America. Maleszewski JJ; Kucirka LM; Segev DL; Halushka MK Cardiovasc Pathol; 2011; 20(5):261-5. PubMed ID: 20822924 [TBL] [Abstract][Full Text] [Related]
30. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre. Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602 [TBL] [Abstract][Full Text] [Related]
31. Sustained elevated concentrations of cardiac troponin T during acute allograft rejection after heart transplantation in children. Wåhlander H; Kjellström C; Holmgren D Transplantation; 2002 Oct; 74(8):1130-5. PubMed ID: 12438959 [TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance spectroscopy for assessing myocardial rejection in the transplanted rat heart. Walpoth BH; Tschopp A; Lazeyras F; Galdikas J; Tschudi J; Altermatt H; Schaffner T; Aue WP; Althaus U J Heart Lung Transplant; 1993; 12(2):271-82. PubMed ID: 8476901 [TBL] [Abstract][Full Text] [Related]
33. The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary. Winters GL; Marboe CC; Billingham ME J Heart Lung Transplant; 1998 Aug; 17(8):754-60. PubMed ID: 9730423 [No Abstract] [Full Text] [Related]
34. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. Yousem SA; Berry GJ; Cagle PT; Chamberlain D; Husain AN; Hruban RH; Marchevsky A; Ohori NP; Ritter J; Stewart S; Tazelaar HD J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):1-15. PubMed ID: 8820078 [TBL] [Abstract][Full Text] [Related]
35. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. Meirovich YF; Veinot JP; de Bold ML; Haddad H; Davies RA; Masters RG; Hendry PJ; de Bold AJ J Heart Lung Transplant; 2008 Jan; 27(1):31-7. PubMed ID: 18187084 [TBL] [Abstract][Full Text] [Related]
36. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. Rose AG; Cooper DK J Heart Lung Transplant; 1996 Aug; 15(8):804-17. PubMed ID: 8878763 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation. Zwirska-Korczala K; Zakliczyński M; Berdowska A; Zembala M; Jochem J; Gajewska K J Heart Lung Transplant; 2005 Apr; 24(4):411-5. PubMed ID: 15797741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]